Igor Denizarde Bacelar Marques

Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease

Rodrigo Azevedo de Oliveira, Fellype Carvalho Barreto, Monique S. Mendes et al. · Kidney International · 2014 · 72 citations

Bone Disease, Hemodialysis, Sclerostin +10

A Randomized Trial of Zoledronic Acid to Prevent Bone Loss in the First Year after Kidney Transplantation

Igor Denizarde Bacelar Marques, Maria Júlia Correia Lima Nepomuceno Araújo, Fabiana G. Graciolli et al. · Journal of the American Society of Nephrology · 2019 · 49 citations · Full text

Clinical features and outcomes of tuberculosis in kidney transplant recipients in <scp>B</scp>razil: a report of the last decade

Igor Denizarde Bacelar Marques, Luiz Sérgio Azevedo, Lı́gia Camera Pierrotti et al. · Clinical Transplantation · 2013 · 46 citations

Anaphylactic reaction induced by a polysulfone/polyvinylpyrrolidone membrane in the 10th session of hemodialysis with the same dialyzer

Igor Denizarde Bacelar Marques, Karina França PINHEIRO, Lílian Pires de Freitas do Carmo et al. · Hemodialysis International · 2011 · 44 citations

Hemodialysis, Urology, Hemodialysis Patients +14

Comparison of serum levels with bone content and gene expression indicate a contradictory effect of kidney transplantation on sclerostin

Maria Júlia Correia Lima Nepomuceno Araújo, Igor Denizarde Bacelar Marques, Fabiana G. Graciolli et al. · Kidney International · 2019 · 20 citations

Urology, Transplantation, Xenotransplantation +13